Punjab Chemicals & Crop Protection Ltd

- The company has incurred about INR 22 crores in capex funded entirely from internal accruals, primarily at existing sites (Derabassi and Lalru). - Regarding a new Greenfield site for agrochemicals, several locations (both Greenfield and Brownfield) have been shortlisted, and a final decision is expected in the next 1-2 quarters. - No explicit mention was made of immediate plans for new fundraising through debt or equity. - The management is in continuous discussion with banks to reduce borrowing costs and optimize working capital. - Any future capex or expansion plans will be evaluated based on market conditions and ongoing customer discussions before proceeding.

- Regular capex ongoing at existing sites (Lalru and Derabassi), with around INR 22 crores spent recently for asset renewal and efficiency improvements. - Plans to start building a new production block post-April/May to cater to two new products; another capex phase expected by end of the current year or early next year. - Evaluation underway for a new site (Greenfield and Brownfield options) for agrochemical business; final decision expected in the next couple of quarters. - Expansion plan includes a new production block in the agrochemical site at Derabassi. - Capex is being carefully evaluated in light of current market conditions, with management expecting conditions to improve and revisiting investments accordingly.

- Existing products are expected to grow around 10-15% in FY25, with potential to increase further. - New products launched are anticipated to add INR 200-250 crores in additional revenue in the current financial year. - There's a planned launch of 7-8 new products between FY24 to FY27, with commercial quantities to start rolling out by Q1 or Q2 of next year. - Over the next 4-5 years, the company targets consistent revenue CAGR of 10-15%, aiming to increase to 25-30% growth in 3-5 years. - Volume growth saw marginal decline due to pricing and inventory levels, but volumes are expected to improve post Q3-Q4 of FY25 as inventory normalizes. - The company is optimistic about gradual growth despite challenging market conditions, leveraging a strong product pipeline and supply chain.

- Existing molecules expected to grow 10%-15% in FY26, possibly more. - New molecules to contribute additional INR 200-250 crores revenue this financial year. - Targeting consistent 10%-15% CAGR growth in revenue for next 1-2 years, increasing to 25%-30% growth in 3-5 years. - New products in the pipeline (3-4 agrochemicals and 3-4 performance chemicals) to drive accelerated growth. - Improved gross margins around 40% sustainable due to better product mix and R&D-led cost efficiencies. - Moderate volume growth expected post inventory normalization in 2025-26, supporting earnings growth. - Capex planned for new production blocks and a new site to support future growth. - Focus on innovation, sustainability, operational excellence expected to drive profitability in turbulent markets.

- Punjab Chemicals and Crop Protection Limited currently has a pipeline of approximately 15 products under development. - Out of these, 7-8 products are pending launch, with expected clarity and rollout plans by Q1 or Q2 of FY25 (next year). - Three agrochemical products have received registration; one is in commercial production while two others are expected to start commercial supply by Q4 FY25 or early FY26. - Registration delays have occurred due to challenging global market conditions, but customer interest remains strong, ensuring business continuity. - The company expects commercial quantities for three other products to begin post-2025 (FY26). - Supply agreements for some new advanced intermediates and specialty chemicals are expected to be finalized in 2-3 quarters. - A new production block and potential new site are being evaluated to support the expansion.